Yuste-Chaves Manuela, Cañueto Javier, Santos-Briz Ángel, Ciria Sara, González-Sarmiento Rogelio, Unamuno Pablo
Department of Dermatology, University Hospital of Salamanca, Salamanca, Spain.
Pediatr Dermatol. 2011 Jul-Aug;28(4):447-50. doi: 10.1111/j.1525-1470.2010.01206.x. Epub 2010 Jul 29.
The Buschke-Ollendorff syndrome (BOS) (MIM 166700) is a rare autosomal dominant disorder with highly variable expression that consists of multiple cutaneous elastic nevi and osteopoikilosis. It may exhibit clinical variations, and in some patients either skin or bone lesions may be absent. Recently it has been demonstrated that the heterozygous loss of function in LEMD3 can result in osteopoikilosis, BOS, and melorheostosis. We have studied three generations in a family with BOS with a variable phenotype. The genetic analyses revealed a heterozygous c.2203C>T nonsense mutation at the LEMD3 locus. The mutation induces a change in the 735 arginine codon to a stop codon. This study shows the wide phenotypic variation in BOS and increases the repertory of mutations described to date in LEMD3.
布希克-奥伦多夫综合征(BOS)(MIM 166700)是一种罕见的常染色体显性疾病,表现高度可变,包括多发性皮肤弹性痣和骨斑点症。它可能表现出临床变异,在一些患者中可能不存在皮肤或骨骼病变。最近有研究表明,LEMD3基因杂合功能缺失可导致骨斑点症、布希克-奥伦多夫综合征和骨干发育异常。我们研究了一个具有可变表型的布希克-奥伦多夫综合征家族的三代人。基因分析显示,LEMD3基因座存在一个杂合的c.2203C>T无义突变。该突变导致735位精氨酸密码子变为终止密码子。这项研究显示了布希克-奥伦多夫综合征广泛的表型变异,并增加了迄今为止描述的LEMD3基因突变库。